Search

everythinglearnresearchcommunity

for

Search:↓

N-acetylcysteine may help treat trichotillomania.

N-acetylcysteine may help treat trichotillomania.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Trichotillomania is often misdiagnosed as alopecia areata and can be treated effectively with N-acetylcysteine and psychotropic drugs.

New alopecia treatments aim for better results and fewer side effects.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Inositol was not more effective than a placebo in treating trichotillomania.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

The review found that individualized treatment and teamwork are important for trichotillomania, and patients who followed through with treatment often improved.

The document concludes that there is hope for future psychopharmacology research despite challenges in treating schizophrenia.

Cognitive-behavioral therapy with habit reversal training is the most effective treatment for trichotillomania.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.

Hair pulling disorder is treated with therapy and medication; hair loss from tension can be reversed if caught early.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Trichotillomania in dementia may be better treated with dopamine blockers like quetiapine than with SSRIs.

If a child is losing a lot of eyelashes and it keeps happening, doctors should look carefully at their health history because it might be a sign of a different health problem.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

The conclusion is that a team of skin doctors and psychiatrists is needed to better treat patients with mind-skin disorders.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

A special receptor in sensory nerve endings helps control how they respond to stretching.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.